Latest Dabrafenib Stories

Researchers presented findings on Monday at the American Society of Clinical Oncology meeting in Chicago of two experimental treatments that treat advanced melanoma. The two experimental treatments, known as Dabrafenib and Tramentinib, are being developed by GlaxoSmithKline and are showing promising results to combat the deadly skin cancer. The researchers said that the trial on Tramentinib included 322 people, 214 of which took the experimental drug while the rest did chemotherapy....